MetaADEDB 2.0 @ LMMD
Methylergonovine
(NOFOWWRHEPHDCY-DAUURJMHSA-N)
Structure
SMILES
OC(=O)/C=C\C(=O)O.CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CO
Molecular Formula:
C24H29N3O6
Molecular Weight:
455.504
Log P:
1.9653
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
5
TPSA:
142.96
CAS Number(s):
57432-61-8
Synonym(s)
1.
Methylergonovine
2.
Methylergobasin
3.
Methylergometrin
4.
Methergin
5.
Methergine
6.
Methylergometrine
7.
Methylergometrine Maleate
8.
Methylergonovine Maleate
9.
Méthergin
External Link(s)
MeSHD008755
PubChem Compound139077833
5281072
ChEBI6874
CHEMBLCHEMBL1200843
KEGGdr:D00680
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Wrong drug administeredFAERS: 6US FAERS
2Product administered to patient of inappropriate ageFAERS: 4US FAERS
3Wrong product administeredFAERS: 4US FAERS
4Chest PainFAERS: 3US FAERS
5HypercapniaFAERS: 3US FAERS
6OliguriaFAERS: 3US FAERS
7Scan myocardial perfusion abnormalFAERS: 3US FAERS
8Blood creatine phosphokinase increasedFAERS: 2US FAERS
9Drug administered to patient of inappropriate ageFAERS: 2US FAERS
10Neonatal respiratory depressionFAERS: 2US FAERS
11PosturingFAERS: 2US FAERS
12Product packaging confusionFAERS: 2US FAERS
13Accidental exposure to productFAERS: 1US FAERS
14Accidental exposure to product by childFAERS: 1US FAERS
15Accidental overdoseFAERS: 1US FAERS
16Activities of daily living impairedFAERS: 1US FAERS
17AgitationFAERS: 1US FAERS
18AngerFAERS: 1US FAERS
19AnxietyFAERS: 1US FAERS
20Atrial FibrillationFAERS: 1US FAERS
21Blood creatinine increasedFAERS: 1US FAERS
22BradycardiaFAERS: 1US FAERS
23Cerebral vasoconstrictionFAERS: 1US FAERS
24Chest discomfortFAERS: 1US FAERS
25ChillsFAERS: 1US FAERS
26CyanosisFAERS: 1US FAERS
27Drug dose omissionFAERS: 1US FAERS
28Drug label confusionFAERS: 1US FAERS
29Electrocardiogram abnormalFAERS: 1US FAERS
30Exaggerated startle responseFAERS: 1US FAERS
31Feeding disorder neonatalFAERS: 1US FAERS
32General physical health deteriorationFAERS: 1US FAERS
33HyperreflexiaFAERS: 1US FAERS
34HypotensionFAERS: 1US FAERS
35LethargyFAERS: 1US FAERS
36Livedo ReticularisFAERS: 1US FAERS
37MenorrhagiaFAERS: 1US FAERS
38Muscle RigidityFAERS: 1US FAERS
39Myocardial InfarctionFAERS: 1US FAERS
40Neonatal hypotensionFAERS: 1US FAERS
41Neonatal respiratory acidosisFAERS: 1US FAERS
42NervousnessFAERS: 1US FAERS
43PallorFAERS: 1US FAERS
44Product quality issueFAERS: 1US FAERS
45Respiratory distressFAERS: 1US FAERS
46ScreamingFAERS: 1US FAERS
47Seizure like phenomenaFAERS: 1US FAERS
48SirenomeliaFAERS: 1US FAERS
49ThrombosisFAERS: 1US FAERS
50Troponin T increasedFAERS: 1US FAERS
51Troponin increasedFAERS: 1US FAERS
52VasospasmFAERS: 1US FAERS
53VomitingFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.